These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1095213

  • 1. Specific MIF release by rat lymphocytes following incubation with syngeneic anti-tumor "immune" RNA.
    Waldman SR, Pilch YH.
    Cell Immunol; 1975 Jul; 18(1):246-50. PubMed ID: 1095213
    [No Abstract] [Full Text] [Related]

  • 2. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S, Herberman RB, Holden HT.
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [Abstract] [Full Text] [Related]

  • 3. Identification of the principal cell type yielding immune RNA capable of transferring tumor-specific cellular cytotoxicity.
    Wang BS, Onikul SR, Mannick JA.
    Cell Immunol; 1978 Aug; 39(1):27-35. PubMed ID: 699059
    [No Abstract] [Full Text] [Related]

  • 4. Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production.
    Landolfo S, Herberman RB, Holden HT.
    J Immunol; 1978 Aug; 121(2):695-701. PubMed ID: 79613
    [Abstract] [Full Text] [Related]

  • 5. Immune cytolysis of rat tumor cells mediated by syngeneic "immune" RNA.
    Kern DH, Drogemuller CR, Pilch YH.
    J Natl Cancer Inst; 1974 Jan; 52(1):299-302. PubMed ID: 4810971
    [No Abstract] [Full Text] [Related]

  • 6. Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors.
    Varesio L, Herberman RB, Gerson JM, Holden HT.
    Int J Cancer; 1979 Jul 15; 24(1):97-102. PubMed ID: 314424
    [Abstract] [Full Text] [Related]

  • 7. Transfer of tumor immunity with RNA.
    Pilch YH, Ramming KP, Deckers PJ.
    Isr J Med Sci; 1971 Jan 15; 7(1):246-58. PubMed ID: 5545768
    [No Abstract] [Full Text] [Related]

  • 8. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S, Herberman RB, Holden HT.
    J Natl Cancer Inst; 1977 Dec 15; 59(6):1675-83. PubMed ID: 200758
    [Abstract] [Full Text] [Related]

  • 9. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH, Drogemuller CR, Pilch YH.
    Ann N Y Acad Sci; 1976 Dec 15; 276():278-302. PubMed ID: 1071964
    [Abstract] [Full Text] [Related]

  • 10. [Correlation between cytotoxic lymphocytes and cells that synthesize the macrophage migration inhibitory factor in the H-2 system].
    Suslov AP, Egorova SG, Brondz BD.
    Biull Eksp Biol Med; 1975 Oct 15; 80(10):86-90. PubMed ID: 776251
    [Abstract] [Full Text] [Related]

  • 11. RNA extracts of lymphoid cells sensitized to DNP-oligolysines convert nonresponder lymphoid cells to responder cells which release migration inhibition factor.
    Paque RE, Ali M, Dray S.
    Cell Immunol; 1975 Apr 15; 16(2):261-8. PubMed ID: 1090381
    [No Abstract] [Full Text] [Related]

  • 12. The role of immunoglobulin receptors on lymphocytes in production of MIF in guinea pigs.
    Gościcka T.
    Cell Immunol; 1974 Aug 15; 13(2):207-15. PubMed ID: 4141646
    [No Abstract] [Full Text] [Related]

  • 13. Peritoneal macrophage response to leukemia L1210 in syngeneic mice.
    Berd D, Prehn RT.
    J Natl Cancer Inst; 1977 Jun 15; 58(6):1729-34. PubMed ID: 864751
    [No Abstract] [Full Text] [Related]

  • 14. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
    Neumann C, Sorg C.
    Eur J Immunol; 1978 Aug 15; 8(8):582-9. PubMed ID: 359337
    [Abstract] [Full Text] [Related]

  • 15. Antigen-mediated macrophage adherence inhibition.
    Holán V, Hasek M, Bubeník J, Chutná J.
    Cell Immunol; 1974 Jul 15; 13(1):107-16. PubMed ID: 4141644
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests.
    Bubeník J, Indrová M, Nemecková S, Malkovský M, Von Broen B, Pálek V, Anderlíková J.
    Int J Cancer; 1978 Mar 15; 21(3):348-55. PubMed ID: 75857
    [No Abstract] [Full Text] [Related]

  • 18. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS, Hayden M, Langley S, Kaliss N, Smith MR.
    J Immunol; 1975 Apr 15; 114(4):1255-63. PubMed ID: 1078832
    [Abstract] [Full Text] [Related]

  • 19. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
    Svoboda I, Măzuran R, Rabatić S, Silobrcić.
    Int J Cancer; 1977 Mar 15; 19(3):371-7. PubMed ID: 844913
    [Abstract] [Full Text] [Related]

  • 20. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.
    Schlager SI, Paque RE, Dray S.
    Cancer Res; 1975 Aug 15; 35(8):1907-14. PubMed ID: 167938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.